Arrhythmia Disorder
Magnets in some Apple, Microsoft products may interfere with ICDs, pacemakers
Strong magnets in newer portable electronic devices like the Apple AirPods Pro charging case or Microsoft Surface Pen can interfere with pacemakers and implantable cardioverter defibrillators, researchers reported.
Rates of in-hospital cardiac arrest vary widely across US institutions
The incidence of in-hospital cardiac arrest among Medicare beneficiaries varied widely across U.S. hospitals, with the rates lowest in minor teaching hospitals and facilities with higher rates of nurse staffing, researchers reported.
High neck circumference linked to elevated AF risk
High neck circumference was associated with risk for incident atrial fibrillation, according to an analysis published in the Journal of the American Heart Association.
Three-lead Holter monitor for low-risk patients gains FDA 510(k) clearance
Biotricity announced it received 510(k) clearance from the FDA for its three-lead device for ECG and arrhythmia monitoring for use among lower risk patients.
Cardiac mapping platform receives FDA clearance
Abbott announced its cardiac mapping platform for electrophysiology procedures received clearance from the FDA.
Lowering driving restriction to 3 months after ICD implantation may be safe
Reducing the current 6-month driving restriction following a new implantable cardioverter defibrillator to 3 months may be safe, according to data published in Circulation.
Mobile six-lead ECG device added to app marketplace for health providers
AliveCor announced that its six-lead personal ECG mobile device has been made available via KardiaPro on Epic's App Orchard Marketplace for hospitals, health systems and providers.
Fitbit Heart Study: Novel algorithm for wearable devices may identify undiagnosed AF
An algorithm used in Fitbit wearable devices showed the capability to identify asymptomatic atrial fibrillation, according to results of the Fitbit Heart Study presented at the American Heart Association Scientific Sessions.
Noninvasive ECG mapping system for arrhythmia ‘hot spots’ gains FDA clearance
Vektor Medical announced the FDA has given 510(k) clearance for its novel ECG mapping system, designed to map “hot spots” associated with stable or unstable arrhythmias anywhere in the heart.
CAR T-cell therapy linked to cardiovascular, pulmonary adverse effects
Chimeric antigen receptor T-cell therapy appeared associated with various cardiovascular and pulmonary adverse events, according to results of a retrospective pharmacovigilance study.